Oral antiviral therapies for COVID-19 in patients with advanced chronic kidney disease or kidney failure

WJ Cho, D Harden, D Moreno… - Nephrology Dialysis …, 2023 - academic.oup.com
As of December 2022, over 651 million people have been diagnosed with coronavirus
disease 2019 (COVID-19) and 6.6 million people have died of COVID-19 [1]. Chronic kidney …
被引用次数：3 相关文章

Oral antiviral therapies for COVID-19 in patients with advanced chronic kidney disease or kidney failure

WJ Cho, D Harden, D Moreno… - Nephrology Dialysis …, 2023 - academic.oup.com
As of December 2022, over 651 million people have been diagnosed with coronavirus
disease 2019 (COVID-19) and 6.6 million people have died of COVID-19 [1]. Chronic kidney …

Oral antiviral therapies for COVID-19 in patients with advanced chronic kidney disease or kidney failure.

WJ Cho, D Harden, D Moreno, JE Dinulos, PE Hanna… - 2023 - cabidigitallibrary.org
In the context of a sizable healthcare system overseeing the medical needs of 1.5 million
patients in the states of Massachusetts and New Hampshire, our investigation focused on …

[引用][C] Oral antiviral therapies for COVID-19 in patients with advanced chronic kidney disease or kidney failure.

WJ Cho, D Harden, D Moreno, JE Dinulos… - … : Official Publication of …, 2023 - europepmc.org

[引用][C] Oral antiviral therapies for COVID-19 in patients with advanced chronic kidney disease or kidney failure

WJ Cho, D Harden, D Moreno… - … publication of the …, 2023 - pubmed.ncbi.nlm.nih.gov
Oral antiviral therapies for COVID-19 in patients with advanced chronic kidney disease or
kidney failure Oral antiviral therapies for COVID-19 in patients with advanced chronic kidney …